dc.contributor.author | Fıratlı Tuğlular, Ayşe Tülin | |
dc.contributor.author | Pehlivan, Mustafa | |
dc.contributor.author | Sönmez, Mehmet | |
dc.contributor.author | Kabukçu Hacıoğlu, Sibel | |
dc.contributor.author | Saydam, Güray | |
dc.contributor.author | Ayyıldız, Orhan | |
dc.contributor.author | Kaynar, Leylagül | |
dc.contributor.author | Demirkan, Fatih | |
dc.contributor.author | Beksaç, Meral | |
dc.date.accessioned | 2023-03-10T10:39:33Z | |
dc.date.available | 2023-03-10T10:39:33Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.citation | Fıratlı Tuğlular, A. T., Pehlivan, M., Sönmez, M., Kabukçu Hacıoğlu, S., Saydam, G., Ayyıldız, O. ... Beksaç, M. (2022). Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey. Clinical Lymphoma, Myeloma & Leukemia içinde (S190-S191. ss.). | en_US |
dc.identifier.issn | 2152-2650 | |
dc.identifier.issn | 2152-2669 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/10608 | |
dc.description.abstract | ... | en_US |
dc.language.iso | eng | en_US |
dc.publisher | CIG Media Group | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Relapsed/Refractory Multiple | en_US |
dc.subject | Dexamethasone | en_US |
dc.subject | Lenalidomide | en_US |
dc.title | Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey | en_US |
dc.type | conferenceObject | en_US |
dc.relation.ispartof | Clinical Lymphoma, Myeloma & Leukemia | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-2035-9462 | en_US |
dc.identifier.volume | 22 | en_US |
dc.identifier.startpage | S190 | en_US |
dc.identifier.endpage | S191 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.institutionauthor | Kaynar, Leylagül | |
dc.identifier.wosquality | Q3 | en_US |
dc.identifier.wos | 00895909200334 | en_US |